euroscript implements Fast-track CMS solution at Astellas Pharma Europe
Bertrange/Eindhoven, 15 December 2009 – euroscript announced today that its subsidiary euroscript Delt Netherlands has won a Fast-track CMS project with Astellas Pharma Europe in the Netherlands.
euroscript's Fast-track CMS solution is the only configurable solution that enables companies to easily deploy a well-fitted CMS within their EMC environment within a couple of weeks. The solution is based on C6 and EMC | Documentum technology.
Within the initial 3-month project phase, euroscript will implement a Fast-track CMS solution focusing on archiving and retrieval functionalities at Astellas’ Technology, Supply Chain and Manufacturing (TSCM) department. Further solution enhancement and roll-out to other departments and subsidiaries of Astellas worldwide will be discussed in early 2010.
Astellas Pharma aims to modernize its document management system, as the system needs to enable document validation and to ensure proper management of status, ownership, version control, and search-find tools.
To meet Astellas’ requirements, euroscript will follow an iterative approach in implementing the solution. euroscript will work closely with representative users of Astellas’ TSCM department to ensure the system suits Astellas’ actual business requirements. The availability of system prototypes for test and validation by Astellas’ representative users will have an immediate effect on user acceptance and productivity. Thus, the system will also prove its effectiveness and adherence to compliance and security requirements.
"We are pleased to support Astellas Pharma Europe in improving their document management system", said René Blanken, Managing Director of euroscript Delt Netherlands bv. "This implementation of our Fast-track CMS solution in the Netherlands demonstrates our competence in realizing secure content and document management solutions as well as our strong expertise in both C6 and EMC | Documentum applications."
About Astellas Pharma Europe
Astellas Pharma Europe Ltd. is the European subsidiary of Astellas. Astellas Europe employs approximately 3,200 people in Europe and South Africa across Sales and Marketing, Research & Development (R&D), and Manufacturing. Astellas Europe has 20 Sales and Marketing affiliates, three Manufacturing plants, and one R&D centre. Astellas Europe, through Astellas Pharma International, is also responsible for the distribution of the company's products in multiple markets in the Middle East and Africa. Astellas Europe is headquartered just outside London, in Staines.
Astellas Europe is focused on four key therapy areas: Transplantation, Urology, Dermatology, and Anti-infectives. These therapy areas are key to Astellas Europe, and the organisation is committed to continuing to explore opportunities and to developing new products that will better serve patients affected by conditions across these areas.
For more information, visit www.astellas-europe.co.uk
About euroscript
euroscript International is a leader in providing customers with global solutions in content lifecycle management. The euroscript divisions deliver comprehensive solutions that help customers design, build and run content management operations of all sizes. Thanks to its employees’ expertise in the fields of consulting, system integration, language services as well as content and document management, euroscript is able to help businesses worldwide to manage content more efficiently.
With a market presence in over 14 countries, spanning 4 continents, euroscript serves customers in a variety of business sectors including the public sector, aerospace, defence and transport, manufacturing, financial services and energy and environment.
Press contacts:
Suzan Ger | Marketing Coordinator
euroscript International S.A. | 55, rue de Luxembourg | L-8077 Bertrange
T: +352 31 44 11 1
René Blanken | Managing Director
euroscript Delt Netherlands bv & euroscript Delt Belgium sprl/bvba
T: +31 (0)40 250 79 00
PR2009_012, EN